Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Optimal CWmin selection for achieving proportional fairness in multi-rate 802.11e WLANs: test-bed implementation and evaluation
We investigate the optimal selection of minimum contention window values to achieve proportional fairness in a multirate IEEE 802.11e test-bed. Expand
BIOACTIVE POLAR LIPIDS IN OLIVE OIL, POMACE AND WASTE BYPRODUCTS
Olive oil protects against atherosclerosis because of biologically active microconstituents. In this study, total polar lipids from olive oil, pomace, pomace oil and waste byproducts were extracted,… Expand
Penetration of albendazole sulphoxide into hydatid cysts.
The penetration of albendazole sulphoxide, the principal metabolite of albendazole into hydatid cysts (E granulosus) was measured by means of in vitro animal and clinical studies. The drug freely… Expand
Re(I) tricarbonyl complex of 1,10-phenanthroline-5,6-dione: DNA binding, cytotoxicity, anti-inflammatory and anti-coagulant effects towards platelet activating factor.
- M. Kaplanis, G. Stamatakis, V. Papakonstantinou, M. Paravatou-Petsotas, C. Demopoulos, Christiana A. Mitsopoulou
- Chemistry, Medicine
- Journal of inorganic biochemistry
- 1 June 2014
The complex fac-[Re(CO)3(phendione)Cl] (1) (where phendione=1,10-phenanthroline-5,6-dione) has been synthesized and fully characterized by UV-visible, FTIR, and NMR techniques. The DNA binding… Expand
Pyrazinamide and pyrazinoic acid pharmacokinetics in patients with chronic renal failure.
Pharmacokinetics of pyrazinamide and its major metabolite, pyrazinoic acid, were assessed in 10 chronic uremic patients treated by maintenance hemodialysis in comparison with 10 normal subjects. All… Expand
Changes in erythromycin pharmacokinetics induced by renal failure.
- A. Kanfer, G. Stamatakis, J. Torlotin, G. Fredj, S. Kenouch, J. Méry
- Clinical nephrology
- 1 March 1987
As erythromycin ototoxicity appears to be favored by renal insufficiency, its pharmacokinetics were assessed in chronic uremic patients treated by maintenance hemodialysis in comparison with normal… Expand
Platelet-Activating Factor and Its Basic Metabolic Enzymes in Blood of Naive HIV-Infected Patients
Platelet-activating factor (PAF), a mediator of proatherosclerotic inflammatory processes, is also implicated in endothelial dysfunction during human immunodeficiency virus (HIV) infection. We… Expand
Postprandial effects of wine consumption on Platelet Activating Factor metabolic enzymes.
- C. Argyrou, Ioanna C Vlachogianni, G. Stamatakis, C. Demopoulos, Smaragdi Antonopoulou, E. Fragopoulou
- Prostaglandins & other lipid mediators
- 1 May 2017
Platelet Activating factor (PAF) is a potent inflammatory mediator that is involved in the initiation and the prolongation of atherosclerosis. The purpose of the study was to investigate the effect… Expand
Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients
Abstract The aim of this study was to estimate the incidence of COVID-19 disease in the French national population of dialysis patients, their course of illness and to identify the risk factors… Expand